Obesity Pushed by Ivy League and Big Pharma

The liberal establishment has been trying to expand the Cultural Marxist coalition by politicizing obesity. As with most things pernicious, the Ivy League takes part:

The Brown University course, titled “The F-Word: Examining the Science, Culture, and Politics of Fatness,” will take place over one week, from July 8-12, and will introduce students to “Fat Studies,” which the course page describes as an “emerging academic field.” […]

The course will make students examine “the pathologization of fatness in the medical community and the rising prevalence of eating disorders, as well as how fatphobia intersects with other systems of oppression.”

Brown is hardly the only college to encourage students to embrace obesity as a means of achieving cherished “oppressed” status.

Cultural Marxists create and expand aggrieved identity groups to array against normal people, on the principle that a house divided against itself cannot stand. After America collapses into squabbling factions, a new society can theoretically be imposed, enabling leftists to achieve absolute power.

Other than sinister Frankfort School types, who could possibly want to promote obesity, which is a risk factor for type 2 diabetes, high blood pressure, heart disease, stroke, metabolic syndrome, fatty liver diseases, some cancers, breathing problems, osteoarthritis, gout, diseases of the gallbladder and pancreas, kidney disease, pregnancy problems, fertility problems, sexual function problems, and mental health problems? Big Pharma:

A new report and database published by Baron Public Affairs last month outlines pharmaceutical sponsorships for trade organizations promoting obesity as a chronic disease warranting health care coverage rather than a preventable symptom of underlying metabolic dysfunction. One such group with funding from major drug manufacturers Novo Nordisk, Eli Lilly, and Boehringer Ingelheim is the Obesity Action Coalition (OAC), an organization at the center of the far-left movement for “body positivity.”

Pfizer and Amgen have also contributed.

An obesity nonprofit determined to radically destigmatize obesity on behalf of the pharmaceutical industry is akin to Big Tobacco funding a front group to destigmatize smoking.

Except that smoking isn’t politically correct — unless you smoke something that makes you passive and stupid.

Pharmaceutical companies operating in a $4.5 trillion health care industry have an obvious incentive to market supposed “game changer” weight-loss drugs to a chronically overweight population that is fighting a losing war against obesity.

The drugs were developed to treat type 2 diabetes.

Common side effects of the medications include nausea, vomiting, and diarrhea. Some users have reported more severe gastrointestinal issues, such as pancreatitis and stomach paralysis, and the latter condition recently provoked a lawsuit against Eli Lilly and Novo Nordisk.

Then there are the potential psychiatric effects of taking drugs that work by suppressing dopamine. But then, mental illness is another moneymaker for Big Pharma that has been furthered by leftist social engineers.

On tips from WDS 2.0 and Steve T.

The post Obesity Pushed by Ivy League and Big Pharma appeared first on Moonbattery.